(PharmaNewsWire.Com, September 12, 2019 ) Market Overview: An oncolytic virus is a genetically engineered or naturally occurring virus that can imitate in selected terms and kill cancer cells without harming the normal tissues. Oncolytic Virus therapy is a new therapeutic approach for treating cancer and shown promising results globally.
Oncolytic virus therapy market value is accounted for USD XX billion in 2018 and is expected to grow at a CAGR of XX.XX% to reach USD xx billion by 2026.
Market Dynamics: The rising prevalence of cancer cases and increasing development of cancer-treating therapies such as an oncolytic virus is driving the market growth globally. The high cost of oncolytic virus therapy is further affecting market growth, especially in developing countries.
Market Segmentation: By Application Prostate cancer Melanoma Ovarian Cancer Breast Cancer Other
By Drug Class Onxy-15 Talimogene laherparepvec Reolysin RIGVIR Others
Geographical Analysis: By Geography, the market is segmented into: North America Europe South America Asia Pacific The Middle East and Africa
About Us DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information: Sai Kiran Sales Manager at Data M Intelligence Email: info@datamintelligence.com Tel: +1 877 441 4866 Website: www.datamintelligence.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
